63K
1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea
Find entries where: 63K
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea |
Identifiers | 1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea |
Formula | C25 H23 F N8 O2 S2 |
Molecular Weight | 550.631 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc(ccc1c2ccc3nnc(n3n2)Sc4ccc5c(c4)sc(n5)NC(=O)NCCN6CCOCC6)F |
InChI | InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35) |
InChIKey | ODIUNTQOXRXOIV-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 61 |
Chiral Atom Count | 0 |
Bond Count | 66 |
Aromatic Bond Count | 26 |
Drug Info: DrugBank
DrugBank ID | DB15382 |
---|---|
Name | SAR-125844 |
Groups | investigational |
Description | SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors). |
Synonyms | SAR-125844 |
Categories |
|
CAS number | 1116743-46-4 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 25182860 |